BEAM stock

Beam Therapeutics Inc (BEAM) financials · rev $139.7M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Beam Therapeutics Inc (BEAM) rev $139.7M.

Cached annual income statement
LineFY2025FY2024
Revenue$139.7M$63.5M
Operating Income-$383.7M-$415.6M
Net Income-$80.0M-$376.7M
EPS (Diluted)-$0.81-$4.58
Cached annual balance sheet
LineFY2025FY2024
Total Assets$1.48B$1.10B
Current Assets$1.27B$878.1M
Cash & Equivalents$294.9M$282.0M
PP&E$104.5M$111.4M
Total Liabilities$242.8M$370.3M
Current Liabilities$96.9M$182.1M
Shareholders' Equity$1.24B$733.5M
Retained Earnings-$1.64B-$1.57B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$345.1M-$347.2M
CapEx$14.9M$8.95M
Investing Cash Flow-$121.4M$185.0M
Financing Cash Flow$478.0M$7.74M
Net Change in Cash$11.5M-$154.5M
Free Cash Flow-$360.0M-$356.2M
These statements as JSON? API free 100/day

FAQ

What is BEAM P/E and revenue?

Beam Therapeutics Inc (BEAM) rev $139.7M.

What is BEAM revenue?

Beam Therapeutics Inc last cached revenue is $139.7M (FY2025).

Is BEAM profitable?

Beam Therapeutics Inc last cached net income is -$80.0M (FY2025).

What are BEAM total assets?

Beam Therapeutics Inc last cached total assets are $1.48B (FY2025).

What is BEAM free cash flow?

Beam Therapeutics Inc last cached free cash flow is -$360.0M (FY2025).

Not investment advice. Cached statements, not a live tape.